interleukin receptor antagonist
Showing 1 - 25 of >10,000
Netosis During COVID-19, Under Treatment With
Active, not recruiting
- Covid19
-
Paris, France
- +1 more
Mar 30, 2022
Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR
Not yet recruiting
- Pericarditis
- IL1RA Antibody Assay
- suPAR Testing
-
Homburg, Germany
- +8 more
Jun 22, 2023
Intracerebral Haemorrhage Trial in Manchester (IL-1Ra Kineret®, IL-1Ra Placebo)
Completed
- Intracerebral Haemorrhage
- IL-1Ra Kineret®
- IL-1Ra Placebo
-
Manchester, North West, United KingdomSalford Royal NHS Foundation Trust
Oct 4, 2021
Polycystic Ovary Syndrome Trial in Basel (IL-1 receptor antagonist Anakinra)
Completed
- Polycystic Ovary Syndrome
- IL-1 receptor antagonist Anakinra
-
Basel, SwitzerlandUniversity Hospital Basel Endocrinology, Diabetes and Metabolism
Jan 26, 2021
Interleukin 6 Receptor Antagonists in Corona Virus Disease 19
Recruiting
- Corona Virus Infection
- ELISA
-
Assiut, EgyptAssiutU
Feb 2, 2023
Coronavirus Disease(COVID)-19 Acute Respiratory Distress
Recruiting
- COVID
- Acute Respiratory Distress Syndrome
- Angiotensin II
- Interleukin-1 receptor antagonist
-
London, United KingdomGuy's & St Thomas' Hospital
Aug 3, 2021
Healthy Trial in Qingdao (VDJ001, Placebo)
Completed
- Healthy
- VDJ001
- Placebo
-
Qingdao, Shandong, Chinathe Affliated Hospital of Qingdao University
Aug 30, 2023
Rectal Cancer Trial in Frankfurt (drug, radiation, procedure)
Recruiting
- Rectal Cancer
- Kineret 100 MG in 0.67 ML Prefilled Syringe
- +3 more
-
Frankfurt, GermanyUniversity Hospital Goethe University Frankfurt
Aug 23, 2022
LARS - Low Anterior Resection Syndrome Trial in Seoul (Ramosetron)
Not yet recruiting
- LARS - Low Anterior Resection Syndrome
-
Seoul, Jongro-gu, Korea, Republic ofSeoul National University Hospital
Dec 13, 2022
Subarachnoid Hemorrhage Trial in United Kingdom (IL-1Ra, IL-1Ra Placebo)
Recruiting
- Subarachnoid Hemorrhage
- IL-1Ra
- IL-1Ra Placebo
-
Plymouth, Devon, United Kingdom
- +11 more
May 16, 2022
GDM Patients and Serum Amyloid A and Interleukin-1 Receptor
Completed
- Gestational Diabetes
- Serum amyloid A values
- Interleukin-1 (IL-1) receptor antagonist values (A-SAA and IL-1Ra)
-
Istanbul, TurkeyKanuni Sultan Süleyman Training and Research Hospital
May 21, 2020
Safety Issues, Pain, Pancreas Fibrosis Trial in Washington (Proglumide, Placebo)
Recruiting
- Safety Issues
- +2 more
- Proglumide
- Placebo
-
Washington, District of ColumbiaGeorgetown University
Dec 1, 2022
Monitoring Drug Efficacy in Patients With Alzheimer's Disease
Recruiting
- Alzheimer Disease
- AChE inhibitor monotherapy
- AChE inhibitor and NMDA receptor antagonist combination therapy
-
Manila, Metro Manila, PhilippinesPhilippine General Hospital
Mar 24, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Epidermolysis Bullosa Trial in Redwood City (Serlopitant Tablet, Placebo Oral Tablet)
Completed
- Epidermolysis Bullosa
- Serlopitant Tablet
- Placebo Oral Tablet
-
Redwood City, CaliforniaStanford University
Nov 30, 2022
COVID-19 Pnemonia Trial in Spain (Anakinra 149 MG/ML Prefilled Syringe [Kineret])
Completed
- COVID-19 Pnemonia
- Anakinra 149 MG/ML Prefilled Syringe [Kineret]
-
Zaragoza, Aragón, Spain
- +11 more
May 27, 2021
Sleep Initiation and Maintenance Disorders, Stress Disorders, Posttraumatic Trial in San Francisco, Salisbury (Suvorexant,
Recruiting
- Sleep Initiation and Maintenance Disorders
- Stress Disorders, Posttraumatic
- Suvorexant
- Placebo
-
San Francisco, California
- +1 more
Nov 10, 2022
Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)
Not yet recruiting
- Acute Respiratory Distress Syndrome
- Placebo
- Ondansetron Injection
-
Montréal, Quebec, CanadaHôpital Sacré-Coeur de Montréal
Aug 22, 2022
Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)
Recruiting
- Liver Cell Carcinoma
- +7 more
- CATCH T cells
- +2 more
-
Houston, TexasHouston Methodist Hospital
Dec 19, 2022
Neuroblastoma Trial in Houston (GINAKIT Cells, Cyclophosphamide, Fludarabine)
Active, not recruiting
- Neuroblastoma
- GINAKIT Cells
- +2 more
-
Houston, TexasTexas Children's Hospital
Jan 18, 2023
Primary Aldosteronism, Hypertension Trial (Finerenone, Spironolactone)
Not yet recruiting
- Primary Aldosteronism
- Hypertension
- (no location specified)
Apr 3, 2023
PTSD Trial in San Francisco (CORT108297, Placebo)
Not yet recruiting
- PTSD
- CORT108297
- Placebo
-
San Francisco, CaliforniaSan Francisco VA Medical Center, San Francisco, CA
Jul 26, 2022
Interleukin-6 Antagonists in Critically-ill Covid-19 Patients
Not yet recruiting
- COVID-19
- Critical Illness
- IL6 Antagonist
- (no location specified)
Jan 29, 2022
Rotator Cuff Tendinitis, Chronic Pain Trial in Kristiansund (Ketalar, NaCl 9%)
Recruiting
- Rotator Cuff Tendinitis
- Chronic Pain
- Ketalar
- NaCl 9%
-
Kristiansund, NorwayDepartment of Orthopedic Surgery, Kristiansund Hospital
Mar 15, 2022